Article metrics
PDF
Other content recommended for you
- Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy
- Changes in hepatitis C burden and treatment trends in Europe during the era of direct - acting antivirals: a modelling study
- Improving hepatitis C screening and diagnosis in patients born between 1945 and 1965 in a safety - net primary care clinic
- Cost and cost - effectiveness of a real - world HCV treatment program among HIV - infected individuals in Myanmar
- Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study
- Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness - implementation trial evaluating an integrated model of HCV care (DRIVE - C: DRug use & Infections in ViEtnam – hepatitis C)
- Retrospective hepatitis C seroprevalence screening in the antenatal setting — should we be screening antenatal women
- On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
- Impact and costs of a hepatitis C virus screening programme for adults hospitalised at an academic medical centre
- Trends in hepatitis C treatment initiation among HIV / hepatitis C virus - coinfected men engaged in primary care in a multisite community health centre in Maryland: a retrospective cohort study